Monarch Alternative Capital LP's Form 4 filing
Pyxus International, Inc. (PYYX) · filed Feb 23, 2023
- Accession no.
- 0001567619-23-003622
- Filed
- Feb 23, 2023, 4:30 PM ET
- Trade date
- Feb 21, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $20.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Monarch Alternative Capital LPCIK 0001281084 | Director, 10% Owner, Other: See Remarks |
| Monarch GP LLCCIK 0001501100 | Director, 10% Owner, Other: See Remarks |
| Mdra GP LPCIK 0001501101 | Director, 10% Owner, Other: See Remarks |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2023 | Common Stock, no par value ("Common Stock") | SSaleDisposed | −15,199 | $1.34 | −$20,366.66 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Sale resulting from client-specific mandate. Monarch Alternative Capital LP, a Delaware limited partnership ("MAC"), appointed Patrick Bartels to the board of directors of the Issuer as its designee pursuant to Section 2.1(d) of the Shareholders Agreement. As a result, each of MAC, and by virtue of their control of MAC, MDRA GP LP and Monarch GP LLC, may be deemed to be a "director-by-deputization" of the Issuer solely for purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Exhibit List: Exhibit 99.1 - Explanation of Responses